Аrtem А Аrtykov

6PUBLICATIONS
19CO-AUTHORS
Chemical engineering designMolecular targetsMedical devicesGene and molecular therapyNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2024
Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687.

Anne V Yagolovich, Alina A Isakova, Artem A Artykov

|Dec 23, 2022
ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL.

Artem Mishukov, Irina Odinokova, Ekaterina Mndlyan

|Oct 27, 2022
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.

Anne V Yagolovich, Alina A Isakova, Artem A Artykov

|Jun 10, 2022
Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH-DR5-B with Dual VEGFR2 and DR5 Receptor Specificity.

Anne V Yagolovich, Artem A Artykov, Alina A Isakova

|Sep 28, 2021
Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells.

Anne Yagolovich, Andrey Kuskov, Pavel Kulikov

|May 06, 2020
Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B more Efficiently than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors.

Аrtem А Аrtykov, Dmitry A Belov, Victoria O Shipunova

Pageof 1

Frequent Collaborators

4 joint publications

Anne Yagolovich

4 joint publications

Dmitry Dolgikh

3 joint publications

Marine E Gasparian

1 joint publications

Ekaterina A Plotnikova